AEON Biopharma, Inc.: Form SCHEDULE 13D, filed Jan 29, 2026
Filed with the SEC on Jan 29, 2026 and accepted by EDGAR at Jan 29, 2026, 21:24 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-009802. Last ingested by Listed: Nov 3, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.